165 related articles for article (PubMed ID: 23475489)
21. DNA topoisomerases: enzymes that change the shape of DNA.
Austin CA; Fisher LM
Sci Prog; 1990; 74(294 Pt 2):147-61. PubMed ID: 2178281
[TBL] [Abstract][Full Text] [Related]
22. DNA topoisomerases.
Wang JC
Annu Rev Biochem; 1996; 65():635-92. PubMed ID: 8811192
[TBL] [Abstract][Full Text] [Related]
23. Type IA topoisomerases: a simple puzzle?
Viard T; de la Tour CB
Biochimie; 2007 Apr; 89(4):456-67. PubMed ID: 17141394
[TBL] [Abstract][Full Text] [Related]
24. The mapping of DNA topoisomerase sites in vivo: a tool to enlight the functions of topoisomerases.
Borde V; Duguet M
Biochimie; 1998 Mar; 80(3):223-33. PubMed ID: 9615862
[TBL] [Abstract][Full Text] [Related]
25. Bacterial tyrosine kinases: novel targets for antibacterial therapy?
Cozzone AJ
Trends Microbiol; 2009 Dec; 17(12):536-43. PubMed ID: 19853456
[TBL] [Abstract][Full Text] [Related]
26. [Resistance acquisition via the bacterial SOS response: the inducive role of antibiotics].
Da Re S; Ploy MC
Med Sci (Paris); 2012 Feb; 28(2):179-84. PubMed ID: 22377306
[TBL] [Abstract][Full Text] [Related]
27. DNA topoisomerases: structure, function, and mechanism.
Champoux JJ
Annu Rev Biochem; 2001; 70():369-413. PubMed ID: 11395412
[TBL] [Abstract][Full Text] [Related]
28. Bacterial histidine kinases as novel antibacterial drug targets.
Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
[TBL] [Abstract][Full Text] [Related]
29. Specific chemical modification of bacterial type I dehydroquinase--opportunities for drug discovery.
González-Bello C
Future Med Chem; 2015; 7(17):2371-83. PubMed ID: 26599605
[TBL] [Abstract][Full Text] [Related]
30. Molecules that Inhibit Bacterial Resistance Enzymes.
Liu Y; Li R; Xiao X; Wang Z
Molecules; 2018 Dec; 24(1):. PubMed ID: 30583527
[TBL] [Abstract][Full Text] [Related]
31. Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins.
Aravind L; Leipe DD; Koonin EV
Nucleic Acids Res; 1998 Sep; 26(18):4205-13. PubMed ID: 9722641
[TBL] [Abstract][Full Text] [Related]
32. An orthogonal single-molecule experiment reveals multiple-attempt dynamics of type IA topoisomerases.
Gunn KH; Marko JF; Mondragón A
Nat Struct Mol Biol; 2017 May; 24(5):484-490. PubMed ID: 28414321
[TBL] [Abstract][Full Text] [Related]
33. [Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs].
Gintsburg AL; Zigangirova NA; Zorina VV
Vestn Ross Akad Med Nauk; 2008; (10):34-9. PubMed ID: 19140396
[TBL] [Abstract][Full Text] [Related]
34. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
Sanyal G; Doig P
Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
[TBL] [Abstract][Full Text] [Related]
35. Type IA Topoisomerases as Targets for Infectious Disease Treatments.
Seddek A; Annamalai T; Tse-Dinh YC
Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33401386
[TBL] [Abstract][Full Text] [Related]
36. Bacterial and archeal type I topoisomerases.
Tse-Dinh YC
Biochim Biophys Acta; 1998 Oct; 1400(1-3):19-27. PubMed ID: 9748482
[TBL] [Abstract][Full Text] [Related]
37. Hybolites Revisited.
Norris V; Verrier C; Feuilloley M
Recent Pat Antiinfect Drug Discov; 2016; 11(1):16-31. PubMed ID: 27048277
[TBL] [Abstract][Full Text] [Related]
38. Separation and functional analysis of eukaryotic DNA topoisomerases by chromatography and electrophoresis.
Knudsen BR; Straub T; Boege F
J Chromatogr B Biomed Appl; 1996 Sep; 684(1-2):307-21. PubMed ID: 8906479
[TBL] [Abstract][Full Text] [Related]
39. Topoisomerases in human disease.
Epstein RJ
Lancet; 1988 Mar; 1(8584):521-4. PubMed ID: 2893929
[TBL] [Abstract][Full Text] [Related]
40. Studies on DNA polymerases and topoisomerases in archaebacteria.
Forterre P; Elie C; Sioud M; Hamal A
Can J Microbiol; 1989 Jan; 35(1):228-33. PubMed ID: 2541877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
